[{"id":"2645ba49-7e5c-4aee-bc4a-f071a22e14b5","acronym":"BreastIls","url":"https://clinicaltrials.gov/study/NCT03667612","created_at":"2021-01-18T17:59:38.706Z","updated_at":"2024-07-02T16:37:07.003Z","phase":"","brief_title":"Endogenous Mechanisms of Inactivation of the Endothelium Tumor","source_id_and_acronym":"NCT03667612 - BreastIls","lead_sponsor":"Centre Oscar Lambret","biomarkers":" BRCA1 • BRCA2 • CD8 • BRCA • IL2RA • CD4 • CD31 • FOXP3 • PECAM1 • SETD5","pipe":" | ","alterations":" BRCA2 mutation • CD8 expression • BRCA mutation","tags":["BRCA1 • BRCA2 • CD8 • BRCA • IL2RA • CD4 • CD31 • FOXP3 • PECAM1 • SETD5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA2 mutation • CD8 expression • BRCA mutation"],"overall_status":"Unknown status","enrollment":" Enrollment 70","initiation":"Initiation: 01/31/2018","start_date":" 01/31/2018","primary_txt":" Primary completion: 10/01/2019","primary_completion_date":" 10/01/2019","study_txt":" Completion: 10/01/2019","study_completion_date":" 10/01/2019","last_update_posted":"2018-09-12"}]